Published in Medical Letter on the CDC and FDA, October 12th, 2008
The GT LightTouch technology systematically and rapidly scans the cervix to identify cancers and pre-cancers painlessly and non-invasively by analyzing the wavelengths of light reflected from cervical tissue. Since the pivotal trial began, approximately 1,900 women have been tested to demonstrate the technology's accuracy in detecting cervical disease, including an arm of the study that assessed effectiveness of the commercial version of the device and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.